Global reporting on TB in children and adolescents: how far have we come and what remains to be done?

Global reporting on TB in children and adolescents: how far have we come and what remains to be done?

Saved in:

Bibliographic Details
Main Authors:	S. Verkuijl, M. Bastard, A. Brands, K. Viney, T. Masini, F. Mavhunga, K. Floyd, T. Kasaeva
Format:	Article
Language:	English
Published:	International Union Against Tuberculosis and Lung Disease (The Union) 2024-01-01
Series:	IJTLD Open
Subjects:	global reporting tb surveillance children adolescents tuberculosis
Online Access:	https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000001/art00002
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TB prevention activities in the WHO European Region
by: A. Matteelli, et al.
Published: (2024-08-01)

Prevalence of TB-related symptoms and self-reported disability among adult TB survivors
by: A.K. McDonald, et al.
Published: (2024-12-01)

Co-creation of a gender responsive TB intervention in Nigeria: a researcher-led collaborative study
by: Chukwuebuka Ugwu, et al.
Published: (2025-01-01)

Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB elimination
by: M. van den Boom, et al.
Published: (2024-01-01)

Time to be seen and heard: Including children’s and adolescents’ voices in the South African TB response
by: C Goslett, et al.
Published: (2024-07-01)

ASA, NSAIDs, Coxibs and Colorectal Cancer Prevention — How Far Have We Come?
by: Martin Fishman
Published: (2004-01-01)

Mapping TB incidence across districts in Uganda to inform health program activities
by: N.J. Henry, et al.
Published: (2024-05-01)

Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment
by: D. T. Wademan, et al.
Published: (2024-02-01)

Progress in programmatic management of drug-resistant TB, WHO Eastern Mediterranean Region, 2018-2023
by: K. Bennani, et al.
Published: (2024-09-01)

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB
by: A. Vasquez, et al.
Published: (2024-07-01)

The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland
by: A. Nowinski, et al.
Published: (2025-01-01)

Innovations in TB Screening and Preventive Therapy Services for PLHIV in Yogyakarta City, Indonesia
by: Dani Catrianiningsih, et al.
Published: (2025-01-01)

Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV
by: R. Borse, et al.
Published: (2024-09-01)

3HP preventive treatment among children and adolescents with HIV and child household contacts of TB patients
by: A. Kinikar, et al.
Published: (2024-09-01)

Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?
by: E. Pontali, et al.
Published: (2024-11-01)

The TB burden in East Java, Indonesia, post-COVID-19
by: S. Palupi, et al.
Published: (2024-08-01)

A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020
by: M.L. Rekart, et al.
Published: (2024-07-01)

Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan
by: S. Moe, et al.
Published: (2024-09-01)

Comprehensive care for people affected by TB: addressing TB-associated disabilities
by: M. Calvi, et al.
Published: (2024-05-01)

TB drug susceptibility testing in high fluoroquinolone resistance settings
by: F. Saluzzo, et al.
Published: (2024-05-01)

Severe outcomes among adults with TB during COVID-19
by: T. Jacobs, et al.
Published: (2024-07-01)

More is needed to end TB: commentary on the United Nations High-Level Meeting on TB
by: G. B. Migliori, et al.
Published: (2024-01-01)

Applicability of TB-LAMP test for diagnosis of pulmonary TB among HIV-positive individuals
by: B. Muriithi, et al.
Published: (2025-01-01)

Modeling TB and HIV co-infections
by: Lih-Ing W. Roeger, et al.
Published: (2009-08-01)

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB
by: R. Crowder, et al.
Published: (2024-10-01)

TB and poverty: the effect of rifampicin-resistant TB on household income
by: A. Ciobanu, et al.
Published: (2024-04-01)

Mathematical analysis of the transmission dynamics of HIV/TB coinfection in the presence of treatment
by: Oluwaseun Sharomi, et al.
Published: (2007-12-01)

Stool Xpert® MTB/RIF Ultra for TB diagnosis in children: experience from a national scale-up programme
by: S. Kabir, et al.
Published: (2024-10-01)

Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
by: The Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):, et al.
Published: (2024-05-01)

Assessing for comorbidities, determinants and disability during TB treatment
by: K. Viney, et al.
Published: (2024-02-01)

Factors that shape the integration of HIV and TB services in Zomba District, Malawi
by: Alex F. Maseko, et al.
Published: (2025-02-01)

Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settings
by: M. Mbenga, et al.
Published: (2024-04-01)

The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet—Remaining Challenges in Hepatitis C
by: Nicholas van Buuren, et al.
Published: (2016-01-01)

Timeliness metrics for screening and preventing TB in household contacts of pulmonary TB patients in Kenya
by: D. Nair, et al.
Published: (2024-01-01)

Burden and challenges in managing TB infection among people with occupational exposure to silica in India
by: B. Kalottee, et al.
Published: (2024-11-01)

Differentiated TB care matrix: Validating an assessment tool for healthcare workers providing differentiated TB care using Delphi technique
by: Riswana S. Ansari, et al.
Published: (2025-03-01)

Rethinking latent TB? Think again
by: R.E. Chaisson, et al.
Published: (2024-08-01)

Children and providers’ perspectives on once-weekly rifapentine and isoniazid TB preventive therapy
by: A.J. Marthinus, et al.
Published: (2025-01-01)

The intersection of TB and health financing: defining needs and opportunities
by: W.A. Wells, et al.
Published: (2024-09-01)

HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing
by: J.S. Zifodya, et al.
Published: (2024-05-01)